or gray mixture of dried shredded leaves, stems and seed and flower of the plant Cannabis sativa. Cannabis has been in use for about 12,000 years in china. Early uses include cure for rheumatic pain, constipation, malaria, absentmindedness, and menstrual cramps.
INTRODUCTION CONTD. Medical marijuana was bottled and legally sold in pharmacies between 1842 to 1890 in US, before the government prohibited its usage due to increased abuse. The use resurfaced in the early 1960s when researchers began to explore into the medical benefit of the plant. Many states in the world have legalised the use of cannabis. INTRODUCTION CONTD.
INTRODUCTION CONTD. In January 2014,Marijuana was noted by the National Institute on Drug Abuse as being the most widely used drug in the U.S.
Globally about 2.9-3.4% of the world population was said to have at least one time tasted marijuana in 2008.
In Africa, Papua New Guinea is the largest consumer not only in the continent but in the world at large.
In Nigeria, about 33.66% of the nations population takes marijuana. Northwest geopolitical zone and Katsina state in particular has the highest number of consumers as reported by NDLEA.
MODES OF INTAKE It is smoked in a pipe like cigarette also called joint.
Typical joint weights 0.5-1.0 g and contains 20+mg of THC.
About 50-129 ng/ml of THC is recorded in the blood plasma immediately after it is smoked (Huestis.1992)
They could also be mixed with food and taken together.
They can even be brewed with tea i.e in coffee and beverages.
Medical Marijuana as it is now medically called have been found to contain about 600 chemical compound.
Among the natural cannabinoids , the most well known are tetrahydrocannabinoid ( 9-THC)
Cannabidol (CBD) which is devoid of any psycho- activity and is the compound responsible for the medical benefits.
Other synthetic cannabinoids includes; Nabilone , cesamet , dronabinoid , levanatrodol MECHANISM OF ACTION OF CANNABINOID When marijuana is inhaled , the compounds rapidly pass from the lungs into the bloodstream and is carried to the brain and other organs throughout the body.
It is absorbed more slowly when ingested in food or drink.
The chemical compound from marijuana acts upon specific molecular targets in the brain called cannabinoids receptors (CB receptors).
The binding starts off a chain of cellular reaction that leads to many reactions including the euphoria or high experienced by the users. Localization of CB Receptors The main cannabis receptors are located in: Olfactory areas Basal ganglia Cerebellum Spinal cord CB1 Receptorpresent throughout CNS Hippocampus Cortex
CB2 receptor located peripherally, linked with immune system Spleen -- Macrophages
HEALTH BENEFITS PREVENTS THE SPREAD OF CANCER CELL Cannabinoids in cannabis plant prevents the cancer cells from spreading and they contribute to cancer cell death by heating some receptors that are generally up-regulated in cancer cells (Bifulco, 2006). Researchers found that a marijuana compound can stop the metastasis in some aggressive cancers. Last year , a similar study found that non-psychoactive cannabinoids resulted in dramatic reductions in cell viability and caused a simultaneous arrest at all phases of the cell cycle in leukemia patients.
CHRONIC PAIN KILLER Marijuana works in the same mechanism as the opiate in acute pain relieve (Noyes, 1975). They attach to the target proteins in the brain and peripheral neurons system that are related to pain. The binding results in the blockage of transmission of pain message to the brain. The binding of marijuana to receptor in CNS causes some adverse effect like
TREATMENT FOR EPILEPSY Since they are classified as schedule drugs by the Drug Enforcement agency(DEA) it is difficult to conduct epilepsy research using these agents. Researchers investigated the effect on voltage-gated Na+(NaV) channels which is common antiepileptic drug target. Cannabidiol (CBD) at small quantity in human blocks the NaV channels and murine neurons and recombinant cells. TREATMENT FOR GLAUCOMA THC and CBD has been established to be neuro-protective and antioxidants (Galve 2008). Glaucoma represents a progressive vascular retinopathy that requires a neuro-protectant like THC and CBD to preserve vision. Resultant optic nerve damage results from hyperexcitability, an effect that THC and CBD can counter also as a neuro- protective antioxidant. The primary benefit of glaucoma patient is its decreasing effect on intra-ocular pressure. TREATMENT FOR NAUSEA AND APPETITE Cancer society in U.K declared that cancer patient in chemotherapy use cannabis to regain their appetite. CB1 receptors that associates with cannabinoids are responsible for the stimulation of eating behavior including; The section of the hypothalamus and hind brain that regulate food intake. The reward centre of brain-helping food makes us feel better. From within stomach and intestinal tissue helping us know when we are hungry. The limbic forebrain helping food seem more palatable(Jesudason.2008). PREVENT OPIATE ADDICTION. Medical marijuana have also been found to reduce opiate addiction because it acts as such effective medication (Calignano, 1998).
Though marijuana and opiate have almost the same mechanism of action in pain relieving.
Opiate has been realized to have more addictive qualities.
Replacing opiate with medical marijuana can help reduce the dependence on opiate based medication. CONCLUSION Marijuana is a popular drug, it is estimated that one third of the worlds population uses it.
Marijuana is a drug with exceptional medical possibilities, though we do not have to smoke or eat it to derive the benefit.
A distinction must be made between raw or crude marijuana and marijuana component. REFERENCES Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585- 614, 1996.[PUBMED Abstract]
Bifulco M, Laezza C, Pisanti S, et al.: Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 148 (2): 123-35, 2006
Calignamo et al (1998), Control of Pain by Endogenous Cannabis: ds, notore 394: 277-281.
Galve-Roperh et al (2008) four current Pharmacological design;Vol 14.
Jesudason D, Wittert G. Endocannabinoid system in food intake and metabolic regulation.Curr Opin Lipidol2008;19: 344348. |Article|PubMed|ChemPort
Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system.Handb Exp Pharmacol2005;168: 299325. |PubMed|ChemPort|
Noyes B, S.F frank, D.H harvey, ande Canter A. (1975) The Analgesic Effect of tetracannabidol. Journal of clinical pharmacology.